Skip to main content

Arcus Biosciences Inc (RCUS) Insider Trading

In the last 90 days, no Arcus Biosciences Inc (RCUS) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 21, 2026Alexander AzoyChief Accounting OfficerSale2,827$30.00$84,810
Jul 10, 2026Juan C. JaenPresidentSale68,569$29.63$2,031,919
Jun 24, 2026Juan C. JaenPresidentSale31,431$27.92$877,500
Jun 1, 2026Alexander AzoyChief Accounting OfficerSale2,562$25.77$66,024
May 11, 2026Robert C. Goeltz IIChief Financial OfficerSale7,763$25.63$198,966

Common questions

RCUS insider trading FAQ

Are RCUS insiders buying or selling?
No RCUS insiders reported open-market purchases or sales in the last 90 days.
When was the last RCUS insider purchase?
No open-market insider purchase of Arcus Biosciences Inc stock was reported in the last 90 days.
Where does RCUS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Arcus Biosciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.